NOK:NYSENokia Corporation Sponsored Analysis
Data as of 2026-08-30 - not real-time
$10.21
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $10.21, Nokia Oyj shows no decisive moving-average alignment, leaving the trend neutral. RSI sits at 48.4, which reads as neutral, and MACD momentum is bullish. Watch $8.77 as support and $11.13 as the nearer resistance level.
Valuation screens as fair: a P/E of 72.9 sits above the sector average of 35.7. Consensus targets land 47.1% above where the shares trade now. Revenue is growing at 8.4% on a 3.5% profit margin. The 1.60% dividend yield looks stretched against payout coverage.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 62.4%, a beta of 1.83 and a maximum drawdown of 50.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.
Valuation screens as fair: a P/E of 72.9 sits above the sector average of 35.7. Consensus targets land 47.1% above where the shares trade now. Revenue is growing at 8.4% on a 3.5% profit margin. The 1.60% dividend yield looks stretched against payout coverage.
Risk scores 9 out of 10, which is high for this asset class. With 30-day volatility of 62.4%, a beta of 1.83 and a maximum drawdown of 50.1%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 96 on the fear-greed composite.
This one splits by horizon — buy in the near term, hold further out, at 3/10 long-term conviction.
Top Market Events
Nokia Oyj NOK shares are trending on Wednesday.Nokia Oyj NOK reports a 9% increase in net sales and significant growth in AI and Cloud, despite facing negative free...Nokia Oyj stock has delivered a strong 200.
Market Outlook
Short Term
< 1 yearPositive
Model confidence: 4/10
Key Factors
- Trading above the 200-day average of 9.53
- MACD momentum is positive
- 30-day volatility of 62.4%
Medium Term
1–3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 72.9 versus sector average of 35.7
- Dividend yield of 1.60% looks stretched against payout coverage
- Trading above the 200-day average of 9.53
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 72.9 versus sector average of 35.7
- Dividend yield of 1.60% looks stretched against payout coverage
- Analyst targets imply +47.1% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth8.40%
Profit Margin3.47%
P/E Ratio72.9
ROE3.45%
ROA3.12%
Debt/Equity15.78
P/B Ratio2.3
Op. Cash Flow$1.1B
Free Cash Flow$1.2B
Industry P/E35.7
Technical Analysis
TrendNeutral
RSI48.4
Support$8.77
Resistance$11.13
MA 20$10.05
MA 50$10.92
MA 200$9.53
MACDBullish
VolumeStable
Fear & Greed Index95.66
Valuation
Fair Value$4.19
Target Price$15.02
Upside/Downside47.13%
GradeFair
TypeBlend
Dividend Yield1.60%
Risk Assessment
Beta1.83
Volatility62.40%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.